Literature DB >> 22104035

Cardiac event risk in Japanese subjects estimated using gated myocardial perfusion imaging, in conjunction with diabetes mellitus and chronic kidney disease.

Kenichi Nakajima1, Shinro Matsuo, Chio Okuyama, Tsuguru Hatta, Kazumasa Tsukamoto, Shigeyuki Nishimura, Akira Yamashina, Hideo Kusuoka, Tsunehiko Nishimura.   

Abstract

BACKGROUND: Cardiac event risk is estimated using quantitative gated myocardial perfusion imaging (MPI) and clinical background in patients with ischemic heart disease. The aim of the present study was to calculate major cardiac event risk and tabulate it in the Heart Risk Table for clinical use of risk stratification. METHODS AND
RESULTS: Multivariate logistic regression was performed based on a multicenter prognostic database (Japanese Assessment of Cardiac Events and Survival Study by Quantitative Gated Single-photon emission computed tomography [J-ACCESS investigation]) using MPI (n=2,395). The risk of major cardiac events (cardiac death, non-fatal myocardial infarction and heart failure requiring hospitalization) was estimated using age, ejection fraction (EF), estimated glomerular filtration rate (eGFR) and presence of diabetes mellitus (DM). Age-matched standard eGFR was determined in 77 subjects. Major cardiac event risk was calculated using the equation: risk (%/3 years)=1/(1+Exp(-(-4.699-0.0151×eGFR+0.7998×DM+0.0582×age+0.697×SSS-0.0359×EF))×100, where SSS refers to summed stress scores. Risk was determined without eGFR (the initial version) and using the present formula with eGFR (revised version), with consistent results. DM and chronic kidney disease were major determinants of cardiac events.
CONCLUSIONS: Cardiac event risk was estimated using MPI defect score and left ventricular EF in conjunction with eGFR and the presence of DM. The risk table might be used for risk evaluation in Japanese patients undergoing MPI.

Entities:  

Mesh:

Year:  2011        PMID: 22104035     DOI: 10.1253/circj.cj-11-0857

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Ischemia and inflammation on chronic kidney disease.

Authors:  Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2017-07-27       Impact factor: 5.952

2.  Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.

Authors:  Kenichi Nakajima; Satoko Nakamura; Hiroki Hase; Yasuchika Takeishi; Shigeyuki Nishimura; Yuhei Kawano; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2018-06-12       Impact factor: 5.952

3.  Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Wesley T O'Neal; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

4.  Prognostic risk stratification based on left ventricular mechanical dyssynchrony in patients at low or intermediate risk of major cardiac events using the J-ACCESS risk model.

Authors:  Masatsugu Miyagawa; Shunichi Yoda; Hidesato Fujito; Takumi Hatta; Yudai Tanaka; Katsunori Fukumoto; Yasuyuki Suzuki; Naoya Matsumoto; Yasuo Okumura
Journal:  Heart Vessels       Date:  2022-08-12       Impact factor: 1.814

5.  Prediction of cardiac death after adenosine myocardial perfusion SPECT based on machine learning.

Authors:  David Haro Alonso; Miles N Wernick; Yongyi Yang; Guido Germano; Daniel S Berman; Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2018-03-14       Impact factor: 5.952

6.  Myocardial perfusion imaging for predicting cardiac events in Japanese patients with advanced chronic kidney disease: 1-year interim report of the J-ACCESS 3 investigation.

Authors:  Nobuhiko Joki; Hiroki Hase; Yuhei Kawano; Satoko Nakamura; Kenichi Nakajima; Tsuguru Hatta; Shigeyuki Nishimura; Masao Moroi; Susumu Nakagawa; Tokuo Kasai; Hideo Kusuoka; Yasuchika Takeishi; Mitsuru Momose; Kazuya Takehana; Mamoru Nanasato; Shunichi Yoda; Hidetaka Nishina; Naoya Matsumoto; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-15       Impact factor: 9.236

7.  A prediction model for 5-year cardiac mortality in patients with chronic heart failure using ¹²³I-metaiodobenzylguanidine imaging.

Authors:  Kenichi Nakajima; Tomoaki Nakata; Takahisa Yamada; Shohei Yamashina; Mitsuru Momose; Shu Kasama; Toshiki Matsui; Shinro Matsuo; Mark I Travin; Arnold F Jacobson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-25       Impact factor: 9.236

8.  Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.

Authors:  Kenichi Nakajima; Yasuchika Takeishi; Shinro Matsuo; Yoshimitsu Yamasaki; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2012-11-30       Impact factor: 5.952

9.  Efficacy of linagliptin and teneligliptin for glycemic control in type 2 diabetic patients with chronic kidney disease: assessment by continuous glucose monitoring; a pilot study.

Authors:  Kenichi Tanaka; Yosuke Okada; Hiroko Mori; Yoshifumi Inada; Kanako Suzuka; Kohei Uriu; Yoshiya Tanaka
Journal:  Diabetol Int       Date:  2016-03-09

10.  Diagnostic value of thallium-201 myocardial perfusion IQ-SPECT without and with computed tomography-based attenuation correction to predict clinically significant and insignificant fractional flow reserve: A single-center prospective study.

Authors:  Haruki Tanaka; Teruyuki Takahashi; Norihiko Ohashi; Koichi Tanaka; Takenori Okada; Yasuki Kihara
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.